171 related articles for article (PubMed ID: 16195412)
21. CRF receptor type 1 mediates continual hypoxia-induced CRF peptide and CRF mRNA expression increase in hypothalamic PVN of rats.
Xu JF; Chen XQ; Du JZ; Wang TY
Peptides; 2005 Apr; 26(4):639-46. PubMed ID: 15752579
[TBL] [Abstract][Full Text] [Related]
22. Desensitization of corticotropin-releasing factor receptors.
Reisine T; Hoffman A
Biochem Biophys Res Commun; 1983 Mar; 111(3):919-25. PubMed ID: 6301492
[TBL] [Abstract][Full Text] [Related]
23. Transcriptional response to corticotropin-releasing factor in AtT-20 cells.
Peeters PJ; Göhlmann HW; Van den Wyngaert I; Swagemakers SM; Bijnens L; Kass SU; Steckler T
Mol Pharmacol; 2004 Nov; 66(5):1083-92. PubMed ID: 15272051
[TBL] [Abstract][Full Text] [Related]
24. Selective regulation of G protein-coupled receptor-mediated signaling by G protein-coupled receptor kinase 2 in FRTL-5 cells: analysis of thyrotropin, alpha(1B)-adrenergic, and A(1) adenosine receptor-mediated responses.
Iacovelli L; Franchetti R; Grisolia D; De Blasi A
Mol Pharmacol; 1999 Aug; 56(2):316-24. PubMed ID: 10419550
[TBL] [Abstract][Full Text] [Related]
25. Hybrid transgenic mice reveal in vivo specificity of G protein-coupled receptor kinases in the heart.
Eckhart AD; Duncan SJ; Penn RB; Benovic JL; Lefkowitz RJ; Koch WJ
Circ Res; 2000 Jan 7-21; 86(1):43-50. PubMed ID: 10625304
[TBL] [Abstract][Full Text] [Related]
26. Differential regulation of CREB and ERK phosphorylation through corticotropin-releasing factor receptors type 1 and 2 in AtT-20 and A7r5 cells.
Kageyama K; Hanada K; Moriyama T; Imaizumi T; Satoh K; Suda T
Mol Cell Endocrinol; 2007 Jan; 263(1-2):90-102. PubMed ID: 17027144
[TBL] [Abstract][Full Text] [Related]
27. Signaling properties of mouse and human corticotropin-releasing factor (CRF) receptors: decreased coupling efficiency of human type II CRF receptor.
Xiong Y; Xie LY; Abou-Samra AB
Endocrinology; 1995 May; 136(5):1828-34. PubMed ID: 7720627
[TBL] [Abstract][Full Text] [Related]
28. Desensitization of the Y1 cell adrenocorticotropin receptor: evidence for a restricted heterologous mechanism implying a role for receptor-effector complexes.
Baig AH; Swords FM; Noon LA; King PJ; Hunyady L; Clark AJ
J Biol Chem; 2001 Nov; 276(48):44792-7. PubMed ID: 11579104
[TBL] [Abstract][Full Text] [Related]
29. Modulation of histamine H(2) receptor signalling by G-protein-coupled receptor kinase 2 and 3.
Rodriguez-Pena MS; Timmerman H; Leurs R
Br J Pharmacol; 2000 Dec; 131(8):1707-15. PubMed ID: 11139450
[TBL] [Abstract][Full Text] [Related]
30. Desensitization of human renal D1 dopamine receptors by G protein-coupled receptor kinase 4.
Watanabe H; Xu J; Bengra C; Jose PA; Felder RA
Kidney Int; 2002 Sep; 62(3):790-8. PubMed ID: 12164861
[TBL] [Abstract][Full Text] [Related]
31. Activation of the CRF(1) receptor causes ERK1/2 mediated increase in GRK3 expression in CATH.a cells.
Salim S; Hite B; Eikenburg DC
FEBS Lett; 2007 Jul; 581(17):3204-10. PubMed ID: 17583697
[TBL] [Abstract][Full Text] [Related]
32. Receptor selectivity of the cloned opossum G protein-coupled receptor kinase 2 (GRK2) in intact opossum kidney cells: role in desensitization of endogenous alpha2C-adrenergic but not serotonin 1B receptors.
Lembo PM; Ghahremani MH; Albert PR
Mol Endocrinol; 1999 Jan; 13(1):138-47. PubMed ID: 9892019
[TBL] [Abstract][Full Text] [Related]
33. Induction of G protein-coupled receptor kinases 2 and 3 contributes to the cross-talk between mu and ORL1 receptors following prolonged agonist exposure.
Thakker DR; Standifer KM
Neuropharmacology; 2002 Nov; 43(6):979-90. PubMed ID: 12423667
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of protein phosphatases by okadaic acid and calyculin-A differentially modulates hormonal- and forskolin-stimulated formation of cyclic AMP in AtT-20 corticotrophs: effect of pituitary adenylate activating polypeptide and corticotropin-releasing factor.
Koch B; Lutz-Bucher B
Cell Signal; 1994 May; 6(4):467-73. PubMed ID: 7946970
[TBL] [Abstract][Full Text] [Related]
35. Novel high-affinity photoactivatable antagonists of corticotropin-releasing factor (CRF) photoaffinity labeling studies on CRF receptor, type 1 (CRFR1).
Bonk I; Rühmann A
Eur J Biochem; 2000 May; 267(10):3017-24. PubMed ID: 10806401
[TBL] [Abstract][Full Text] [Related]
36. Glucocorticoid modulation of corticotropin-releasing factor desensitization in cultured rat anterior pituitary cells.
Ceda GP; Hoffman AR
Endocrinology; 1986 Jan; 118(1):58-62. PubMed ID: 3000748
[TBL] [Abstract][Full Text] [Related]
37. Corticotropin-releasing factor (CRF) induces desensitization of the rat pituitary CRF receptor-adenylate cyclase complex.
Wynn PC; Harwood JP; Catt KJ; Aguilera G
Endocrinology; 1988 Jan; 122(1):351-8. PubMed ID: 2826113
[TBL] [Abstract][Full Text] [Related]
38. Expression of molecular equivalent of hypothalamic-pituitary-adrenal axis in adult retinal pigment epithelium.
Zmijewski MA; Sharma RK; Slominski AT
J Endocrinol; 2007 Apr; 193(1):157-69. PubMed ID: 17400813
[TBL] [Abstract][Full Text] [Related]
39. Regulation of corticotropin-releasing factor receptor function in human Y-79 retinoblastoma cells: rapid and reversible homologous desensitization but prolonged recovery.
Hauger RL; Dautzenberg FM; Flaccus A; Liepold T; Spiess J
J Neurochem; 1997 Jun; 68(6):2308-16. PubMed ID: 9166723
[TBL] [Abstract][Full Text] [Related]
40. Corticotropin-releasing factor type 1 and type 2alpha receptors regulate phosphorylation of calcium/cyclic adenosine 3',5'-monophosphate response element-binding protein and activation of p42/p44 mitogen-activated protein kinase.
Rossant CJ; Pinnock RD; Hughes J; Hall MD; McNulty S
Endocrinology; 1999 Apr; 140(4):1525-36. PubMed ID: 10098484
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
